FI63751C - Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat - Google Patents
Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat Download PDFInfo
- Publication number
- FI63751C FI63751C FI762258A FI762258A FI63751C FI 63751 C FI63751 C FI 63751C FI 762258 A FI762258 A FI 762258A FI 762258 A FI762258 A FI 762258A FI 63751 C FI63751 C FI 63751C
- Authority
- FI
- Finland
- Prior art keywords
- tert
- compounds
- formula
- butylaminopropoxy
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1071475 | 1975-08-15 | ||
CH1071475 | 1975-08-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI762258A FI762258A (xx) | 1977-02-16 |
FI63751B FI63751B (fi) | 1983-04-29 |
FI63751C true FI63751C (fi) | 1983-08-10 |
Family
ID=4366041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI762258A FI63751C (fi) | 1975-08-15 | 1976-08-06 | Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat |
Country Status (28)
Country | Link |
---|---|
US (1) | US4434176A (xx) |
JP (2) | JPS5223073A (xx) |
AT (1) | AT363070B (xx) |
AU (1) | AU505719B2 (xx) |
BE (1) | BE845197R (xx) |
CA (1) | CA1080720A (xx) |
CY (1) | CY1225A (xx) |
DE (1) | DE2635209C2 (xx) |
DK (1) | DK152120C (xx) |
ES (1) | ES450681A1 (xx) |
FI (1) | FI63751C (xx) |
FR (1) | FR2320743A2 (xx) |
GB (2) | GB1575510A (xx) |
HK (1) | HK35884A (xx) |
IE (1) | IE43797B1 (xx) |
IL (2) | IL50263A (xx) |
KE (1) | KE3404A (xx) |
MY (1) | MY8500135A (xx) |
NL (2) | NL176362C (xx) |
NO (1) | NO762735L (xx) |
NZ (1) | NZ181764A (xx) |
PH (1) | PH13356A (xx) |
PT (1) | PT65477B (xx) |
SE (1) | SE414633B (xx) |
SG (1) | SG84883G (xx) |
SU (1) | SU649313A3 (xx) |
YU (1) | YU198876A (xx) |
ZA (1) | ZA764883B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2830211A1 (de) * | 1977-07-21 | 1979-02-01 | Sandoz Ag | Substituierte indol-derivate, ihre herstellung und verwendung |
JPS58106499A (ja) * | 1981-12-19 | 1983-06-24 | 株式会社東芝 | 燃料交換装置のクランプ解除機構 |
NL8600137A (nl) * | 1985-02-05 | 1986-09-01 | Sandoz Ag | Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten. |
US5174210A (en) * | 1990-04-27 | 1992-12-29 | Heidelberger Druckmaschinen Aktiengesellschaft | Preparation of the inking unit of a printing press for a change of printing job |
JPH09508378A (ja) * | 1994-01-28 | 1997-08-26 | シーエーエル・インターナショナル・リミテッド | エステル化可能なβ遮断薬のサリチレートを含む医薬製造物 |
NZ543741A (en) * | 2003-05-30 | 2009-10-30 | Ranbaxy Lab Ltd | Substituted pyrrole derivatives and their use as HMG-Co inhibitors |
US8026377B2 (en) * | 2005-11-08 | 2011-09-27 | Ranbaxy Laboratories, Limited | Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt |
AR059838A1 (es) * | 2006-03-14 | 2008-04-30 | Ranbaxy Lab Ltd | Formulaciones para dosis estabilizantes de estatina |
WO2008010087A2 (en) * | 2006-07-14 | 2008-01-24 | Ranbaxy Laboratories Limited | Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH532040A (de) * | 1970-03-24 | 1972-12-31 | Sandoz Ag | Verfahren zur Herstellung neuer Indolderivate |
US3751429A (en) * | 1970-03-24 | 1973-08-07 | Sandoz Ltd | 4-(3-amino-2-substituted propoxy)indole derivatives |
SE375771B (xx) * | 1970-09-30 | 1975-04-28 | Sandoz Ag | |
CH545784A (en) * | 1971-01-07 | 1974-02-15 | Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles | |
CH545783A (en) * | 1971-01-07 | 1974-02-15 | Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides |
-
1976
- 1976-08-05 DE DE2635209A patent/DE2635209C2/de not_active Expired
- 1976-08-06 DK DK357576A patent/DK152120C/da not_active IP Right Cessation
- 1976-08-06 FI FI762258A patent/FI63751C/fi not_active IP Right Cessation
- 1976-08-06 NO NO762735A patent/NO762735L/no unknown
- 1976-08-06 SE SE7608865A patent/SE414633B/xx unknown
- 1976-08-11 NL NLAANVRAGE7608902,A patent/NL176362C/xx active Protection Beyond IP Right Term
- 1976-08-12 FR FR7624659A patent/FR2320743A2/fr active Granted
- 1976-08-12 YU YU01988/76A patent/YU198876A/xx unknown
- 1976-08-13 GB GB13931/79A patent/GB1575510A/en not_active Expired
- 1976-08-13 IL IL50263A patent/IL50263A/xx unknown
- 1976-08-13 GB GB33753/76A patent/GB1575509A/en not_active Expired
- 1976-08-13 ZA ZA00764883A patent/ZA764883B/xx unknown
- 1976-08-13 CY CY1125A patent/CY1225A/xx unknown
- 1976-08-13 ES ES450681A patent/ES450681A1/es not_active Expired
- 1976-08-13 IE IE1791/76A patent/IE43797B1/en not_active IP Right Cessation
- 1976-08-13 AU AU16841/76A patent/AU505719B2/en not_active Expired
- 1976-08-13 PT PT65477A patent/PT65477B/pt unknown
- 1976-08-13 PH PH18788A patent/PH13356A/en unknown
- 1976-08-13 SU SU762388420A patent/SU649313A3/ru active
- 1976-08-13 AT AT0602576A patent/AT363070B/de not_active IP Right Cessation
- 1976-08-13 BE BE169821A patent/BE845197R/xx active
- 1976-08-13 NZ NZ181764A patent/NZ181764A/xx unknown
- 1976-08-13 CA CA259,050A patent/CA1080720A/en not_active Expired
- 1976-08-14 JP JP51096629A patent/JPS5223073A/ja active Granted
-
1979
- 1979-09-03 IL IL58163A patent/IL58163A0/xx unknown
-
1980
- 1980-05-23 JP JP6800480A patent/JPS5649318A/ja active Pending
-
1982
- 1982-05-06 US US06/375,369 patent/US4434176A/en not_active Expired - Lifetime
-
1983
- 1983-12-29 SG SG848/83A patent/SG84883G/en unknown
-
1984
- 1984-04-19 KE KE3404A patent/KE3404A/xx unknown
- 1984-04-26 HK HK358/84A patent/HK35884A/xx unknown
-
1985
- 1985-12-30 MY MY135/85A patent/MY8500135A/xx unknown
-
1993
- 1993-07-02 NL NL930134C patent/NL930134I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6354321A (ja) | 血糖降下剤 | |
JP2008266333A (ja) | Ltb4−アンタゴニスト活性を有するベンズアミジン誘導体及びその医薬としての使用 | |
JPS62167752A (ja) | フエニルアセトニトリル誘導体その医薬組成物および哺乳動物におけるカルシウムイオンきつ抗作用または抗高圧作用促進方法 | |
FI63751C (fi) | Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(3-tert-butylaminopropoxi)-2-metyl-indolderivat | |
EP0022118A1 (fr) | Nouveaux dérivés de sulfonyl-aniline, leur procédé de préparation et leur application en thérapeutique | |
FI84057C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva fluorallylaminderivat. | |
KR100352899B1 (ko) | 새로운3-페닐설포닐-3,7-디아자바이사이클로[3,3,1]노난-화합물을함유하는약제 | |
EP0364350B1 (fr) | Dérivés de méthyl-4[(phényl-4 pipérazinyl-1)-2 éthyl]-5 thiazole, leur procédé de préparation et les compositions pharmaceutiques en contenant | |
FR2631827A1 (fr) | Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique | |
US4880841A (en) | Process of producing phenethylamine derivatives | |
Erhardt et al. | Ultra-short-acting. beta.-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy) propanolamines having esters on the aryl function | |
EP0143016B1 (fr) | Dérivés de 4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-1-yl-N-phényl acétamide, leur préparation et leur application en thérapeutique | |
EP0138684B1 (fr) | 2-(N-pyrrolidino)-3-isobutoxy-N-phenyl substitué N-benzyl propylamines, leur préparation et leur application pharmaceutique | |
JPH0441149B2 (xx) | ||
FR2510571A1 (fr) | Spirothiazolidinedione, son procede de production et preparation pharmaceutique la contenant | |
FR2502619A1 (fr) | Derives de la 1(2h)-isoquinolone et leurs utilisations therapeutiques notamment dans le traitement des ulceres | |
US4100280A (en) | 1,3-Dialkyl-6,7-methoxy-1H-1,2,4-benzothiadiazine-1-oxides | |
EP0168245A2 (en) | Basic oxime ethers, pharmaceutical compositions possessing antianginal activityand the use of basic oxime ethers for manufactoring medicaments for the treatment of angina | |
FR2571965A1 (fr) | Medicaments a base de nouveaux derives de la 4 h-dioxino-(4,5-c)-pyridine. | |
US5371088A (en) | 1-aryl-4-piperazinylcyclohexanecarbonitriles, the preparation and use thereof | |
EP0275760B1 (fr) | Pipéridines, ou azépines substituées, leur préparation et leur application en thérapeutique | |
EP0103500A2 (fr) | Dérivés de phénéthyl-1alpha-phényl-pipéridine-3-propanenitrile, leur préparation et leur application en thérapeutique | |
RU2015964C1 (ru) | Способ получения замещенных производных амина | |
JPH0351711B2 (xx) | ||
EP0347305A1 (fr) | [(Aryl-4-pipérazinyl-1)-2 éthoxy]-3 p-cymène, les dérivés ortho, méta, para monosubstitués ou disubstitués sur le noyau phényle dudit produit, le procédé de préparation desdits dérivés, et les médicaments contenant lesdits composés comme principe actif |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired | ||
MA | Patent expired |
Owner name: SANDOZ AG |